PFG Investments LLC Sells 6,045 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

PFG Investments LLC reduced its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 28.3% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 15,340 shares of the exchange traded fund’s stock after selling 6,045 shares during the period. PFG Investments LLC’s holdings in SPDR S&P Biotech ETF were worth $1,382,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new position in SPDR S&P Biotech ETF in the third quarter worth $141,284,000. Mirae Asset Securities USA Inc. boosted its stake in SPDR S&P Biotech ETF by 50.0% during the third quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares in the last quarter. Assetmark Inc. increased its holdings in SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the period. Finally, Whittier Trust Co. increased its holdings in SPDR S&P Biotech ETF by 3.3% in the 3rd quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock valued at $30,729,000 after buying an additional 9,976 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.2 %

Shares of XBI opened at $92.61 on Tuesday. The company has a 50-day moving average price of $93.35 and a two-hundred day moving average price of $96.87. The stock has a market cap of $7.06 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.